-+ 0.00%
-+ 0.00%
-+ 0.00%

Wolfe Research Upgrades Janux Therapeutics to Outperform, Announces $23 Price Target

Benzinga·08/24/2026 12:17:56
Listen to the news
Wolfe Research analyst Kalpit Patel upgrades Janux Therapeutics (NASDAQ:JANX) from Peer Perform to Outperform and announces $23 price target.